MedTrace Logo

WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

NCT04701684 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 594

Last updated 2026-03-05

No results posted yet for this study

Summary

The WE-TRUST study is a multi-center randomized clinical trial to assess the impact of a Direct to Angio Suite (DTAS) workflow on stroke patient outcomes.

Conditions

  • Stroke, Acute

Interventions

PROCEDURE

Conventional CT/MR triage

First a CT or MRI exam is acquired for triage. In case of an ischemic stroke the patient is then treated in an interventional suite.

DEVICE

Direct to Angio Suite (DTAS) Philips' CBCT triage

Stroke patients are diagnosed and treated (mechanical thrombectomy) in the same angio suite

Sponsors & Collaborators

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Principal Investigators

  • Raul G Nogueira · UPMC Stroke Institute, Pittsburgh

  • Marc Ribo · Vall d'Hebron University Hospital, Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-23
Primary Completion
2027-04-01
Completion
2027-04-01
FDA Device
Yes

Countries

  • United States
  • Argentina
  • Belgium
  • Brazil
  • France
  • Germany
  • Netherlands
  • Romania
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04701684 on ClinicalTrials.gov